$NKTR NEKTAR THERAPEUTICS Insider Trading Week 14/2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEKTAR THERAPEUTICS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NEKTAR THERAPEUTICS in week 14/2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 12 2018 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Option Exercise | M | 7.21 | 502 | 3,619 | 32,500 | |
| Apr 12 2018 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Sell | S | 105.67 | 502 | 53,046 | 80,261 | 80.8 K to 80.3 K (-0.62 %) |
| Apr 12 2018 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Buy | M | 7.21 | 502 | 3,619 | 80,763 | 80.3 K to 80.8 K (+0.63 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Option Exercise | M | 9.24 | 30,000 | 277,200 | 10,000 | |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Option Exercise | M | 9.24 | 30,000 | 277,200 | 10,000 | |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Sell | S | 101.74 | 30,000 | 3,052,200 | 27,450 | 57.5 K to 27.5 K (-52.22 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Sell | S | 101.74 | 30,000 | 3,052,200 | 27,450 | 57.5 K to 27.5 K (-52.22 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Buy | M | 9.24 | 30,000 | 277,200 | 57,450 | 27.5 K to 57.5 K (+109.29 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Buy | M | 9.24 | 30,000 | 277,200 | 57,450 | 27.5 K to 57.5 K (+109.29 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Option Exercise | M | 7.21 | 9,498 | 68,481 | 33,002 | |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Option Exercise | M | 7.21 | 9,498 | 68,481 | 33,002 | |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Option Exercise | M | 7.21 | 20,000 | 144,200 | 42,500 | |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Option Exercise | M | 7.21 | 20,000 | 144,200 | 42,500 | |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Sell | S | 105.05 | 9,498 | 997,765 | 80,261 | 89.8 K to 80.3 K (-10.58 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Sell | S | 105.05 | 9,498 | 997,765 | 80,261 | 89.8 K to 80.3 K (-10.58 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Buy | M | 7.21 | 9,498 | 68,481 | 89,759 | 80.3 K to 89.8 K (+11.83 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Buy | M | 7.21 | 9,498 | 68,481 | 89,759 | 80.3 K to 89.8 K (+11.83 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Sell | S | 101.75 | 20,000 | 2,035,000 | 80,261 | 100.3 K to 80.3 K (-19.95 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Sell | S | 101.75 | 20,000 | 2,035,000 | 80,261 | 100.3 K to 80.3 K (-19.95 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Buy | M | 7.21 | 20,000 | 144,200 | 100,261 | 80.3 K to 100.3 K (+24.92 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Buy | M | 7.21 | 20,000 | 144,200 | 100,261 | 80.3 K to 100.3 K (+24.92 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | M | 14.26 | 30,000 | 427,800 | 0 | |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | M | 14.26 | 30,000 | 427,800 | 0 | |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Sell | S | 92.22 | 30,000 | 2,766,600 | 130,333 | 160.3 K to 130.3 K (-18.71 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Sell | S | 92.22 | 30,000 | 2,766,600 | 130,333 | 160.3 K to 130.3 K (-18.71 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Buy | M | 14.26 | 30,000 | 427,800 | 160,333 | 130.3 K to 160.3 K (+23.02 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Buy | M | 14.26 | 30,000 | 427,800 | 160,333 | 130.3 K to 160.3 K (+23.02 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Option Exercise | M | 7.21 | 49,500 | 356,895 | 0 | |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Option Exercise | M | 7.21 | 49,500 | 356,895 | 0 | |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Option Exercise | M | 7.21 | 500 | 3,605 | 49,500 | |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Option Exercise | M | 7.21 | 500 | 3,605 | 49,500 | |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Option Exercise | M | 7.21 | 50,000 | 360,500 | 0 | |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Option Exercise | M | 7.21 | 50,000 | 360,500 | 0 | |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Option Exercise | M | 10.69 | 60,000 | 641,400 | 0 | |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Option Exercise | M | 10.69 | 60,000 | 641,400 | 0 | |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Sell | S | 96.13 | 49,500 | 4,758,435 | 67,394 | 116.9 K to 67.4 K (-42.35 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Sell | S | 96.13 | 49,500 | 4,758,435 | 67,394 | 116.9 K to 67.4 K (-42.35 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Buy | M | 7.21 | 49,500 | 356,895 | 116,894 | 67.4 K to 116.9 K (+73.45 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Buy | M | 7.21 | 49,500 | 356,895 | 116,894 | 67.4 K to 116.9 K (+73.45 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Sell | S | 91.69 | 110,500 | 10,131,745 | 67,394 | 177.9 K to 67.4 K (-62.12 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Sell | S | 91.69 | 110,500 | 10,131,745 | 67,394 | 177.9 K to 67.4 K (-62.12 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Buy | M | 7.21 | 500 | 3,605 | 177,894 | 177.4 K to 177.9 K (+0.28 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Buy | M | 7.21 | 500 | 3,605 | 177,894 | 177.4 K to 177.9 K (+0.28 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Buy | M | 7.21 | 50,000 | 360,500 | 177,394 | 127.4 K to 177.4 K (+39.25 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Buy | M | 7.21 | 50,000 | 360,500 | 177,394 | 127.4 K to 177.4 K (+39.25 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Buy | M | 10.69 | 60,000 | 641,400 | 127,394 | 67.4 K to 127.4 K (+89.03 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Buy | M | 10.69 | 60,000 | 641,400 | 127,394 | 67.4 K to 127.4 K (+89.03 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Option Exercise | M | 5.14 | 15,000 | 77,100 | 15,000 | |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Option Exercise | M | 5.14 | 15,000 | 77,100 | 15,000 | |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Option Exercise | M | 14.26 | 10,000 | 142,600 | 20,000 | |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Option Exercise | M | 14.26 | 10,000 | 142,600 | 20,000 | |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Sell | S | 92.14 | 15,000 | 1,382,100 | 274,223 | 289.2 K to 274.2 K (-5.19 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Sell | S | 92.14 | 15,000 | 1,382,100 | 274,223 | 289.2 K to 274.2 K (-5.19 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Buy | M | 5.14 | 15,000 | 77,100 | 289,223 | 274.2 K to 289.2 K (+5.47 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Buy | M | 5.14 | 15,000 | 77,100 | 289,223 | 274.2 K to 289.2 K (+5.47 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Sell | S | 92.15 | 10,000 | 921,500 | 274,223 | 284.2 K to 274.2 K (-3.52 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Sell | S | 92.15 | 10,000 | 921,500 | 274,223 | 284.2 K to 274.2 K (-3.52 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Buy | M | 14.26 | 10,000 | 142,600 | 284,223 | 274.2 K to 284.2 K (+3.65 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Buy | M | 14.26 | 10,000 | 142,600 | 284,223 | 274.2 K to 284.2 K (+3.65 %) |